David Cole to Adult
This is a "connection" page, showing publications David Cole has written about Adult.
Connection Strength
0.231
-
Bias-free identification of a linear model-predictive steering controller from measured driver steering behavior. IEEE Trans Syst Man Cybern B Cybern. 2012 Apr; 42(2):434-43.
Score: 0.028
-
Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study. BMC Cancer. 2008 Feb 20; 8:55.
Score: 0.021
-
Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007 Jun 01; 68(2):354-8.
Score: 0.020
-
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004 Jun; 239(6):828-37; discussion 837-40.
Score: 0.016
-
A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent. Surgery. 1999 Sep; 126(3):510-7.
Score: 0.012
-
Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients. Am Surg. 1998 Jun; 64(6):539-43; discussion 543-4.
Score: 0.011
-
Stereotactic core biopsy of the breast: results of one-year follow-up of 101 patients. Am Surg. 1997 Dec; 63(12):1124-7.
Score: 0.010
-
Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge. Hum Gene Ther. 1996 Jul 10; 7(11):1381-94.
Score: 0.009
-
The impact of surgical diversion before neoadjuvant therapy for rectal cancer. Am Surg. 2015 May; 81(5):444-9.
Score: 0.009
-
Postoperative complications in patients receiving suramin therapy. Surgery. 1994 Jul; 116(1):90-5.
Score: 0.008
-
Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):837-44.
Score: 0.008
-
Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. J Natl Cancer Inst. 1994 Jan 05; 86(1):39-45.
Score: 0.008
-
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. Ann Surg. 2013 Dec; 258(6):879-86.
Score: 0.008
-
Melanoma of the external ear. J Surg Oncol. 1992 Jun; 50(2):110-4.
Score: 0.007
-
Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis. Br J Cancer. 1992 May; 65(5):783-5.
Score: 0.007
-
Complications of hepatic resection for colorectal carcinoma metastasis. Am Surg. 1992 Feb; 58(2):88-91.
Score: 0.007
-
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:312-20.
Score: 0.006
-
Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. Am J Surg. 2010 Feb; 199(2):204-9.
Score: 0.006
-
Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008 Oct-Dec; 7(4):305-9.
Score: 0.005
-
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother. 2009 Jan; 58(1):49-59.
Score: 0.005
-
Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. Int J Cancer. 2007 Apr 01; 120(7):1511-7.
Score: 0.005
-
Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn. 2003 Nov; 5(4):237-42.
Score: 0.004
-
Factors influencing choice between mastectomy and lumpectomy for women in the Carolinas. J Surg Oncol. 2001 Jan; 76(1):6-12.
Score: 0.003
-
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. Br J Cancer. 2000 Jul; 83(1):16-21.
Score: 0.003
-
Trends in indications and outcomes in the Whipple procedure over a 40-year period. Am Surg. 1999 Sep; 65(9):889-93.
Score: 0.003
-
Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens. Cytokine. 1996 Jan; 8(1):42-8.
Score: 0.002